IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.704
NA - Nord America 1.388
AS - Asia 1.044
SA - Sud America 140
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 16
AN - Antartide 1
Totale 4.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.304
RU - Federazione Russa 782
CN - Cina 380
SG - Singapore 359
IT - Italia 271
RO - Romania 266
BR - Brasile 116
SE - Svezia 115
HK - Hong Kong 92
DE - Germania 81
VN - Vietnam 74
FR - Francia 54
CA - Canada 51
GB - Regno Unito 44
BD - Bangladesh 40
FI - Finlandia 26
IN - India 26
NL - Olanda 16
MX - Messico 14
PL - Polonia 12
JP - Giappone 11
AR - Argentina 10
IQ - Iraq 10
AT - Austria 8
PH - Filippine 8
ID - Indonesia 7
TR - Turchia 7
ZA - Sudafrica 7
IE - Irlanda 6
CO - Colombia 5
EG - Egitto 5
ES - Italia 5
LT - Lituania 5
CR - Costa Rica 4
JM - Giamaica 4
UA - Ucraina 4
VE - Venezuela 4
GT - Guatemala 3
NP - Nepal 3
PK - Pakistan 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
EE - Estonia 2
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
PY - Paraguay 2
UZ - Uzbekistan 2
AQ - Antartide 1
BG - Bulgaria 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 4.293
Salva come PNG Salva come JPEG
Città #
Dallas 223
Ashburn 188
Singapore 188
Moscow 154
San Jose 149
Hong Kong 90
Milan 77
Shanghai 73
Beijing 67
Munich 47
New York 44
Council Bluffs 41
Los Angeles 40
Hefei 36
Ho Chi Minh City 33
Lauterbourg 32
Santa Clara 27
Phoenix 23
Rome 22
Princeton 21
Lawrence 20
Boardman 19
Orem 19
Helsinki 17
Montreal 15
São Paulo 14
Atlanta 13
Toronto 11
Warsaw 11
Boston 10
Chicago 10
Hanoi 10
Amsterdam 9
Brooklyn 9
Houston 9
Nuremberg 9
Denver 8
Frankfurt am Main 8
Pietra Ligure 8
Cesano Boscone 7
Chennai 7
Guangzhou 7
London 7
Manchester 7
Miami 7
Miano 7
Tokyo 7
Johannesburg 6
Seattle 6
Turku 6
Mexico City 5
New Delhi 5
Shenzhen 5
Stockholm 5
Turin 5
Ancona 4
Ankara 4
Bologna 4
Brescia 4
Florence 4
Las Vegas 4
Newark 4
Pune 4
Quezon City 4
The Dalles 4
Baghdad 3
Baie-D'Urfé 3
Ballincollig 3
Bari 3
Barnet 3
Bexley 3
Brasília 3
Buffalo 3
Cairo 3
City of London 3
Da Nang 3
Detroit 3
Dublin 3
Falkenstein 3
Genoa 3
Jundiaí 3
Kingston 3
Milwaukee 3
Mumbai 3
Naples 3
North Bergen 3
Osimo 3
Paris 3
Poli 3
Poplar 3
Pottstown 3
Rio de Janeiro 3
Salvador 3
San Antonio 3
San Francisco 3
San Giuliano 3
Tampa 3
Verona 3
Vittoria 3
York 3
Totale 2.048
Salva come PNG Salva come JPEG
Nome #
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 402
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 211
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 195
Biobanking for COVID-19 research 157
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 144
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 142
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 139
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 129
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 128
Drug retention rates of biological agents in adult onset Still's disease 124
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 118
COVID-19: Pharmacology and kinetics of viral clearance 115
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 112
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 111
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 108
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 107
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 106
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 104
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 104
Obesity and its role in the management of rheumatoid and psoriatic arthritis 103
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 102
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 102
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 101
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 101
Current treatment options and safety considerations when treating adult-onset Still’s disease 100
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease 92
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 91
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 80
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 78
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 78
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 75
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 74
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 73
Low prevalence of arrhythmias in clinically stable COVID-19 patients 71
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 66
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 66
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort 62
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 59
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 53
Totale 4.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025909 56 15 21 28 42 50 358 66 92 36 47 98
2025/20262.455 169 167 183 286 181 66 203 197 687 148 68 100
2026/2027484 57 116 128 183 0 0 0 0 0 0 0 0
Totale 4.383